Advertisement
U.S. Markets closed

Innate Pharma S.A. (IPH.PA)

Paris - Paris Delayed Price. Currency in EUR
1.8700-0.0240 (-1.27%)
At close: 05:35PM CEST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
51,901
51,901
49,580
12,110
56,155
-
Cost of Revenue
-
-
-
-
3,042
45,158
Gross Profit
-
-
-
-
53,791
23,815
Operating Expense
64,570
64,570
66,005
59,937
55,076
-
Operating Income
-12,669
-12,669
-16,425
-47,827
1,079
-
Net Non Operating Interest Income Expense
2,537
2,537
258
15
223
-
Other Income Expense
2,562
2,562
-41,805
2,330
-2,131
-
Pretax Income
-7,570
-7,570
-57,972
-45,478
-829
-
Tax Provision
0
0
0
0
0
-
Net Income Common Stockholders
-7,570
-7,570
-58,103
-52,809
-63,984
-
Diluted NI Available to Com Stockholders
-7,570
-7,570
-58,103
-52,809
-63,984
-
Basic EPS
-0.79
-0.09
-0.73
-0.66
-0.81
-
Diluted EPS
-0.79
-0.09
-0.73
-0.66
-0.81
-
Basic Average Shares
79,923
84,111
79,640
79,543
78,935
-
Diluted Average Shares
79,923
84,111
79,640
79,543
78,935
-
Total Operating Income as Reported
-12,669
-12,669
-57,425
-47,825
1,079
-
Rent Expense Supplemental
-
-
-
-
1,702
1,872
Total Expenses
64,570
64,570
66,005
59,937
55,076
-
Net Income from Continuing & Discontinued Operation
-7,570
-7,570
-58,103
-52,809
-63,984
-
Normalized Income
-10,132
-10,132
-16,167
-47,808
1,302
-
Interest Income
3,177
3,177
546
327
564
-
Interest Expense
640
640
288
312
341
-
Net Interest Income
2,537
2,537
258
15
223
-
EBIT
-6,930
-6,930
-57,684
-45,166
-488
-
EBITDA
-1,839
-1,839
-12,279
-40,570
56,309
-
Reconciled Cost of Revenue
-
-
-
-
3,042
45,160
Reconciled Depreciation
5,091
5,091
45,405
4,596
56,797
-
Net Income from Continuing Operation Net Minority Interest
-7,570
-7,570
-57,972
-45,478
-829
-
Total Unusual Items Excluding Goodwill
2,562
2,562
-41,805
2,330
-2,131
-
Total Unusual Items
2,562
2,562
-41,805
2,330
-2,131
-
Normalized EBITDA
-4,401
-4,401
29,526
-42,900
58,440
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-